EA201692083A1 - Фармацевтическая композиция для ветеринарии и ее применение - Google Patents
Фармацевтическая композиция для ветеринарии и ее применениеInfo
- Publication number
- EA201692083A1 EA201692083A1 EA201692083A EA201692083A EA201692083A1 EA 201692083 A1 EA201692083 A1 EA 201692083A1 EA 201692083 A EA201692083 A EA 201692083A EA 201692083 A EA201692083 A EA 201692083A EA 201692083 A1 EA201692083 A1 EA 201692083A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- veterinary
- gonadorelin
- pharmaceutical composition
- composition
- application
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Pregnancy & Childbirth (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Настоящее изобретение относится к фармацевтической композиции для ветеринарии, содержащей по меньшей мере одно фармацевтически активное с точки зрения ветеринарии вещество, выбранное из гонадорелина и аналогов гонадорелина, а также из солей гонадорелина и аналогов гонадорелина. Настоящее изобретение характеризуется тем, что композиция содержит матрицу, не содержащую липосом, которая обеспечивает замедление высвобождения фармацевтически активного с точки зрения ветеринарии вещества из композиции и которая содержит материал-основу, выбранный из группы, включающей натуральные и синтетические триглицериды, масла растительного происхождения, диацилпропандиолы, диацилбутандиолы и смеси данных веществ, причем фармацевтическая композиция для ветеринарии не содержит биоразлагаемый полимер.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102014207353 | 2014-04-16 | ||
PCT/EP2015/058265 WO2015158823A1 (de) | 2014-04-16 | 2015-04-16 | Veterinärpharmazeutische zusammensetzung und deren verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201692083A1 true EA201692083A1 (ru) | 2017-03-31 |
Family
ID=53052802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201692083A EA201692083A1 (ru) | 2014-04-16 | 2015-04-16 | Фармацевтическая композиция для ветеринарии и ее применение |
Country Status (5)
Country | Link |
---|---|
US (1) | US9956164B2 (ru) |
EP (1) | EP3131532A1 (ru) |
CN (1) | CN106456704A (ru) |
EA (1) | EA201692083A1 (ru) |
WO (1) | WO2015158823A1 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2020283738A1 (en) * | 2019-05-24 | 2021-12-23 | Dechra Veterinary Products, Llc | Long-acting injectable formulations and use thereof |
CN117981715B (zh) * | 2024-04-07 | 2024-07-09 | 中国农业大学 | 一种促进后备母猪初情期启动和改善发情障碍的后备母猪批次化养殖方法 |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE795516A (fr) | 1972-02-17 | 1973-08-16 | Ciba Geigy | Preparations de peptides huileuses et injectables et procede pour leur preparation |
US4675189A (en) | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
DD256605A3 (de) | 1982-12-23 | 1988-05-18 | Adw Ddr | Verfahren zur herstellung von peptidpraeparaten mit verlaengerter wirkung |
CH661206A5 (fr) | 1983-09-23 | 1987-07-15 | Debiopharm Sa | Procede pour la preparation d'un medicament destine au traitement de maladies hormonodependantes. |
US4764378A (en) | 1986-02-10 | 1988-08-16 | Zetachron, Inc. | Buccal drug dosage form |
US5500228A (en) | 1987-05-26 | 1996-03-19 | American Cyanamid Company | Phase separation-microencapsulated pharmaceuticals compositions useful for alleviating dental disease |
IT1243390B (it) | 1990-11-22 | 1994-06-10 | Vectorpharma Int | Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione. |
DE4223169C1 (de) | 1992-07-10 | 1993-11-25 | Ferring Arzneimittel Gmbh | Verfahren zur Mikroverkapselung wasserlöslicher Wirkstoffe |
TW333456B (en) | 1992-12-07 | 1998-06-11 | Takeda Pharm Ind Co Ltd | A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide. |
US5766627A (en) | 1993-11-16 | 1998-06-16 | Depotech | Multivescular liposomes with controlled release of encapsulated biologically active substances |
CA2143044C (en) | 1994-02-21 | 2005-04-12 | Yasutaka Igari | Matrix for sustained-release preparation |
US6117455A (en) | 1994-09-30 | 2000-09-12 | Takeda Chemical Industries, Ltd. | Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent |
CA2192782C (en) | 1995-12-15 | 2008-10-14 | Nobuyuki Takechi | Production of microspheres |
FR2748205A1 (fr) | 1996-05-06 | 1997-11-07 | Debio Rech Pharma Sa | Compositions pharmaceutiques pour la liberation controlee de principes actifs insolubles |
ATE359805T1 (de) | 1996-08-30 | 2007-05-15 | Peptech Ltd | Formulierung zur verzögerten freisetzung von peptidagonisten und -analoga des gnrh |
US5736151A (en) | 1996-12-09 | 1998-04-07 | Pharmacia & Upjohn Company | Antibiotic oil suspensions |
WO1998032423A1 (en) | 1997-01-29 | 1998-07-30 | Takeda Chemical Industries, Ltd. | Sustained-release microspheres, their production and use |
US6051558A (en) | 1997-05-28 | 2000-04-18 | Southern Biosystems, Inc. | Compositions suitable for controlled release of the hormone GnRH and its analogs |
US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
FR2791289B1 (fr) | 1999-03-26 | 2001-05-04 | Skf France | Procede de fabrication d'un galet a roulement |
US6287588B1 (en) | 1999-04-29 | 2001-09-11 | Macromed, Inc. | Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof |
US6720001B2 (en) * | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
MXPA02008261A (es) | 2000-02-24 | 2002-11-29 | Monsanto Technology Llc | Formulaciones inyectables no acuosas para liberacion prolongada de somatotorpina. |
DE10024451A1 (de) * | 2000-05-18 | 2001-11-29 | Asta Medica Ag | Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung |
JP5046447B2 (ja) | 2000-08-07 | 2012-10-10 | 和光純薬工業株式会社 | 乳酸重合体及びその製造方法 |
DE10050831A1 (de) | 2000-10-05 | 2002-05-02 | Veyx Pharma Gmbh | Verfahren zum Zyklusstart bei weiblichen Zuchttieren |
IL139177A0 (en) | 2000-10-20 | 2001-11-25 | S C Republic Dev S R L | Sustained release drug delivery system |
EP1382350A4 (en) | 2001-04-25 | 2006-01-04 | Takeda Pharmaceutical | MEANS AGAINST THE PROPHYLAXIS BEFORE POSTOPERATIVE REPEAT OF PREMOPEOPAUSAL BREAST CANCER |
TWI225416B (en) | 2001-06-29 | 2004-12-21 | Takeda Chemical Industries Ltd | Sustained-release composition and process for producing the same |
AR034641A1 (es) | 2001-06-29 | 2004-03-03 | Takeda Pharmaceutical | Composicion de liberacion controlada y metodo para producirla |
WO2003055470A1 (fr) | 2001-12-26 | 2003-07-10 | Takeda Chemical Industries, Ltd. | Nouvelle microsphere et son procede de production |
US8088726B2 (en) | 2002-06-25 | 2012-01-03 | Takeda Pharmaceutical Company Limited | Process for producing sustained-release composition |
US20040022815A1 (en) | 2002-08-05 | 2004-02-05 | Orchid Health Care | Novel pharmaceutical composition of ceftiofur |
AU2002368261A1 (en) | 2002-10-02 | 2004-04-23 | Yeda Research And Development Co. Ltd. | Long-acting gonadotropin-releasing hormone analogs and methods of use thereof |
US7659061B2 (en) | 2002-11-19 | 2010-02-09 | Pharmacia & Upjohn Company | Pharmaceutical compositions having a modified vehicle |
JO2505B1 (en) | 2003-03-14 | 2009-10-05 | باير شيرنغ فارما اكتنجيسيلشافت | Pharmacy methods and formulations for obtaining acceptable serum testosterone levels |
DE602004015755D1 (de) | 2003-03-31 | 2008-09-25 | Alza Corp | Nicht wässrige einphasige visköse vehikel und formulierungen die diese vehikel verwenden |
JP2007501850A (ja) | 2003-05-09 | 2007-02-01 | ノボソム アーゲー | 作用物質のデリバリーのための注射可能なリポソーム式デポー製剤 |
EP1711159B1 (en) | 2003-12-30 | 2013-03-20 | Durect Corporation | Solid implants containing a block copolymer for controlled release of a gnrh compound |
CN101001640A (zh) | 2004-05-31 | 2007-07-18 | 斯玛特药物***公司 | 缓释组合物 |
JP5127449B2 (ja) | 2004-06-04 | 2013-01-23 | カムルス エービー | 流体デポ製剤 |
TW200613012A (en) | 2004-07-02 | 2006-05-01 | Takeda Pharmaceuticals Co | Sustained-release composition, process for producing the same and use of the same |
CA2582096C (en) | 2004-10-01 | 2014-01-07 | Ramscor, Inc. | Conveniently implantable sustained release drug compositions |
EP1835885A1 (en) | 2004-12-23 | 2007-09-26 | Durect Corporation | Polymeric implants, preferably containing a mixture of peg and plg, for controlled release of a gnrh |
US20060216242A1 (en) | 2005-02-03 | 2006-09-28 | Rohloff Catherine M | Suspending vehicles and pharmaceutical suspensions for drug dosage forms |
US20060100154A1 (en) | 2005-10-13 | 2006-05-11 | Yeda Research And Development Co | Long-acting gonadotropin-releasing hormone analogs and methods of use thereof |
ES2397712T3 (es) | 2006-01-18 | 2013-03-08 | Qps, Llc | Composiciones farmacéuticas con estabilidad reforzada |
TWI481424B (zh) | 2006-12-18 | 2015-04-21 | Takeda Pharmaceutical | 緩釋性組成物及其製法 |
FR2910318B1 (fr) | 2006-12-20 | 2009-07-03 | Flamel Technologies Sa | Dispersion de polyaminoacides dans une phase lipidique continue. |
US20090022727A1 (en) | 2007-01-26 | 2009-01-22 | Alza Corp. | Injectable, nonaqueous suspension with high concentration of therapeutic agent |
GB0705264D0 (en) | 2007-03-20 | 2007-04-25 | Pliva Istrazivanje I Razvoj D | Gel forming compounds |
WO2009114959A1 (zh) | 2008-03-20 | 2009-09-24 | 中国人民解放军军事医学科学院毒物药物研究所 | 可注射用缓释药物制剂及其制备方法 |
KR100963435B1 (ko) | 2008-06-19 | 2010-06-17 | 한국과학기술연구원 | 서방형 약물전달 및 조직재생용 덮인 다공성 생분해성고분자 미립구의 제조 방법 |
EP2210589B1 (en) | 2009-01-22 | 2015-05-06 | Ludwig-Maximilians-Universität München | Vesicular phospholipid gels comprising proteinaceous substances |
CA2784847C (en) | 2009-12-18 | 2017-11-21 | Molly Sandra Shoichet | Injectable polymer composition for use as a cell delivery vehicle |
TWI396696B (zh) | 2010-03-19 | 2013-05-21 | Univ Nat Pingtung Sci & Tech | 一種促進魚類卵黃生成之合成胜肽 |
EP2605751A1 (en) | 2010-08-20 | 2013-06-26 | Dr. Reddy's Laboratories, Ltd. | Phospholipid depot |
-
2015
- 2015-04-16 US US15/304,677 patent/US9956164B2/en not_active Expired - Fee Related
- 2015-04-16 EP EP15720617.8A patent/EP3131532A1/de not_active Withdrawn
- 2015-04-16 CN CN201580020276.9A patent/CN106456704A/zh active Pending
- 2015-04-16 WO PCT/EP2015/058265 patent/WO2015158823A1/de active Application Filing
- 2015-04-16 EA EA201692083A patent/EA201692083A1/ru unknown
Also Published As
Publication number | Publication date |
---|---|
WO2015158823A1 (de) | 2015-10-22 |
US9956164B2 (en) | 2018-05-01 |
CN106456704A (zh) | 2017-02-22 |
US20170189328A1 (en) | 2017-07-06 |
WO2015158823A8 (de) | 2016-12-15 |
EP3131532A1 (de) | 2017-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20160212A (es) | Composiciones y métodos para modular los receptores x farnesoides | |
CL2016002812A1 (es) | Uso de ácido 3-2,3,5,6-tetrafluoro-3-trifluorometoxi-bifenil-4-ilcarbamoil-tiofeno-2-carboxílico para preparar un medicamento útil para tratar una enfermedad ocular que es uveítis, ojo seco o causada por un adenovirus composición formulación. | |
CL2017000562A1 (es) | Extracto concentrado de algae, su método de producción y uso del mismo en la agricultura | |
EA201790069A1 (ru) | Дифторметилникотиновые инданилкарбоксамиды | |
CL2016002072A1 (es) | 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 para el tratamiento de la enfermedad de alzheimer | |
EA201591166A1 (ru) | Ингибиторы аутотаксина | |
CL2016002169A1 (es) | Inhibidores de diacilglicerol aciltransferasa 2 para uso en el tratamiento de trastornos metabólicos y relacionados. | |
DOP2016000226A (es) | Compuestos de isoindolinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados | |
CL2016001918A1 (es) | Heteroaril amidas como inhibidores de agregación de proteína | |
CR20190239A (es) | Inhibidores de la magl | |
CR20160460A (es) | Heterociclos condensados sustituidos como moduladores de gpr119 para el tratamiento de la diabetes, obesidad, dislipidemia y trastornos relacionados | |
BR112016015701A2 (pt) | Dendrímero de peptídeo, método de esterilização do mesmo, composição, composição farmacêutica, método de polimerização de fibrinogênio, kit para formação de um hidrogel e hidrogel | |
SV2016005293A (es) | Compuestos de azol amido-sustituidos como inhibidores de tnks1 y/o tnks2 | |
EA201692043A1 (ru) | Лекарственная форма иммунодепрессанта | |
EA201692392A1 (ru) | Новая лекарственная форма мелоксикама | |
AR096338A1 (es) | (ciano-dimetil-metil)-isoxazoles y -[1,3,4]tiadiazoles | |
DOP2016000251A (es) | Inhibidores de las vías de señalización de wnt | |
EA201692083A1 (ru) | Фармацевтическая композиция для ветеринарии и ее применение | |
EA201691741A1 (ru) | Фармацевтическая композиция | |
EA201791657A1 (ru) | Модуляторы аденозиновых рецепторов a | |
PH12019500024A1 (en) | Pharmaceutical compositions | |
CL2015002643A1 (es) | Uso de ésteres carbónicos acilados de glicerol en agricultura | |
BR112016026422A2 (pt) | solução farmacêutica compreendendo dopamina para uso no tratamento da doença de parkinson | |
CO7170180A2 (es) | Composición farmacéutica inyectable de dexketoprofeno y tramadol | |
BR112017011638A2 (pt) | nanoparticulas para compostos encapsulantes, sua preparação e utilizações |